|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
44,730,000 |
Market
Cap: |
2.96(B) |
Last
Volume: |
156,484 |
Avg
Vol: |
270,938 |
52
Week Range: |
$48.61 - $66.75 |
|
Level
I Sector: |
Financials |
Level
II Sector: |
Real Estate |
Level
III Sector: |
REIT - Healthcare Facilities |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 5 |
Insider 6 Months : 10.9 |
Insider 3/6 Months : 16.3 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile National Health Investors is a real estate investment trust (REIT) focusing on sale-leaseback, joint-venture, mortgage and mezzanine financing of senior housing and medical facility investments. Co.'s portfolio consists of real estate investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, hospitals and medical office buildings. Co.'s investments are structured as acquisitions of properties through purchase-leaseback transactions, acquisitions of properties from other real estate investors, loans or operations via structures allowed by the REIT Investment Diversification Empowerment Act of 2007.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
437 |
10,437 |
11,437 |
13,937 |
Total Buy Value |
$28,768 |
$615,650 |
$667,048 |
$822,543 |
Total People Bought |
1 |
2 |
3 |
4 |
Total Buy Transactions |
1 |
2 |
3 |
5 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-05 |
2023-12-03 |
2023-06-04 |
2022-06-04 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mccabe Robert A Jr |
Director |
|
2024-05-31 |
4 |
B |
$65.83 |
$28,768 |
D/D |
437 |
21,585 |
2.39 |
- |
|
Spaid John L |
CFO/EVP Finance |
|
2024-05-06 |
4 |
D |
$64.72 |
$14,886 |
D/D |
(230) |
18,050 |
|
- |
|
Swafford Charlotte A |
Director |
|
2024-02-27 |
4 |
B |
$58.69 |
$586,882 |
I/I |
10,000 |
110,185 |
2.1 |
11% |
|
Pascoe Kevin Carlton |
Chief Investment Officer |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
39,893 |
|
- |
|
Mendelsohn D. Eric |
CEO and President |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
54,256 |
|
- |
|
Spaid John L |
CFO/EVP Finance |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
18,280 |
|
- |
|
Gaines Kristin Sallee |
SVP/Chief Transaction Officer |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
51,609 |
|
- |
|
Travis David L |
SVP/Chief Accounting Officer |
|
2024-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
7,000 |
|
- |
|
Jobe James R |
Director |
|
2023-08-30 |
4 |
B |
$51.40 |
$51,398 |
D/D |
1,000 |
14,979 |
2.39 |
4% |
|
Spaid John L |
CFO/EVP Finance |
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
15,280 |
|
- |
|
Gaines Kristin Sallee |
SVP/Chief Transaction Officer |
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
48,609 |
|
- |
|
Travis David L |
SVP/Chief Accounting Officer |
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
4,000 |
|
- |
|
Mendelsohn D. Eric |
CEO and President |
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
51,256 |
|
- |
|
Pascoe Kevin Carlton |
Chief Investment Officer |
|
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
36,893 |
|
- |
|
Adams Robert G |
Director |
|
2022-12-14 |
4 |
B |
$56.60 |
$56,600 |
I/I |
1,000 |
180,548 |
2.1 |
-13% |
|
Pascoe Kevin Carlton |
Chief Investment Officer |
|
2022-08-26 |
4 |
D |
$67.10 |
$1,077,962 |
D/D |
(16,065) |
32,893 |
|
- |
|
Pascoe Kevin Carlton |
Chief Investment Officer |
|
2022-08-26 |
4 |
OE |
$53.41 |
$979,166 |
D/D |
18,333 |
48,958 |
|
- |
|
Adams Robert G |
Director |
|
2022-08-15 |
4 |
B |
$65.93 |
$98,895 |
I/I |
1,500 |
85,411 |
2.1 |
-18% |
|
Adams Robert G |
Director |
|
2021-12-30 |
4 |
B |
$57.25 |
$114,500 |
I/I |
2,000 |
170,000 |
2.1 |
-9% |
|
Webb Robert T |
Director |
|
2021-09-30 |
4 |
B |
$53.86 |
$107,715 |
I/I |
2,000 |
39,000 |
2.1 |
-0% |
|
Mendelsohn D. Eric |
CEO and President |
|
2021-09-29 |
4 |
B |
$54.34 |
$108,757 |
D/D |
2,000 |
46,256 |
2.74 |
1% |
|
Webb Robert T |
Director |
|
2021-09-17 |
4 |
B |
$57.25 |
$85,875 |
I/I |
1,500 |
37,000 |
2.1 |
1% |
|
Webb Robert T |
Director |
|
2021-09-16 |
4 |
B |
$57.50 |
$86,250 |
I/I |
1,500 |
35,500 |
2.1 |
-1% |
|
Webb Robert T |
Director |
|
2021-09-14 |
4 |
B |
$58.00 |
$87,000 |
I/I |
1,500 |
34,000 |
2.1 |
1% |
|
Webb Robert T |
Director |
|
2021-09-10 |
4 |
B |
$58.50 |
$87,750 |
I/I |
1,500 |
32,500 |
2.1 |
1% |
|
391 Records found
|
|
Page 1 of 16 |
|
|